Results 171 to 180 of about 21,517 (297)

Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen, Solja Niemelä, Alexander Denissoff, Antti Tanskanen, Ellenor Mittendorfer‐Rutz, Markku Lähteenvuo, Jari Tiihonen, Heidi Taipale   +7 more
wiley   +1 more source

Blood Alcohol Concentration in Finnish Suicide Deaths and Associated Risk Factors, 2016–2024

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Aims There is limited research examining the relationship between blood alcohol concentration (BAC) and other risk factors among suicide deaths in Finland. Our study aimed to investigate the relationship of an elevated (more than zero) blood alcohol concentration with medical history, including sociodemographic characteristics and disease ...
Tristan Pokornyi, Marjut Grainger, Timo Partonen   +2 more
wiley   +1 more source

Chronic Alcoholism and Propofol Demand: The Impact of Alcohol Tolerance in Painless Gastrointestinal Endoscopy. [PDF]

JGH Open
Wang X, Shi Y, Yang H, Tao T, Ji J.
europepmc   +1 more source

Changing public perceptions of alcohol, alcohol harms and alcohol policies: A multi‐methods study to develop novel framing approaches

Addiction, Volume 120, Issue 4, Page 655-668, April 2025.
Abstract Background and aims Public perceptions of alcohol and its related harms and policies are shaped by multiple discourses and can influence behaviour and policy support. As part of a FrameWorks‐informed project to test framing approaches to improve public understanding and support for evidence‐based alcohol policies in the UK, this research aimed
Niamh Fitzgerald, Kathryn Angus, Rebecca Howell, Heather Labhart, James Morris, Laura Fenton, Nicholas Woodrow, Maria Castellina, Melissa Oldham, Claire Garnett, John Holmes, Jamie Brown, Rachel O'Donnell   +12 more
wiley   +1 more source

Licorice-Induced Pseudohyperaldosteronism Highlights an Underestimated Etiology of Hypertension. [PDF]

Kidney Int Rep
Bendjilali-Sabiani JJ, Cardinale A, Lamy A, Pouget AM, Boyer JC, Taillard V, Reboul P.   +6 more
europepmc   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

Café Coronary Deaths: Medicolegal Observations From a Tertiary Care Center. [PDF]

Cureus
Sonwani NS, Thakur K, Ateriya N, Kumar A, Kohli A.   +4 more
europepmc   +1 more source

Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series

Addiction, EarlyView.
Abstract Background and aims Evidence regarding the impacts of supervised drug consumption services (SDC) remains mixed, and few evaluations have used individual‐level, linkable health data to examine service withdrawal. In September 2024, the Red Deer overdose prevention site (OPS) in Alberta, Canada, was scheduled for closure, with operations ceasing
Nathaniel Day, Kym Kaufmann, Daniel John Alexander Devoe, Vanja Grubac, Alessia DiMarzo, Haisa Osmanli, Vanessa Norton, Shelly Vik, Nickie Mathew, Robert Lawrence Tanguay, Anees Bahji   +10 more
wiley   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source

Neurocognitive Disorders and Their Factors in Chronic Consumers of Artisanal Alcohol, Tshitshiampa: A Study From Demba Territory, Central Kasaï Province. [PDF]

Cureus
Tshibuabua PM, Tshitoko JN, Muteba EV, Bumoko GM.   +3 more
europepmc   +1 more source